Clinical Trials List
2015-04-20 - 2019-12-31
Phase II
Terminated4
ICD-10C67
Malignant neoplasm of bladder
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yu-Chieh Tsai Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- Yu-Min Yeh Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- 陳政哲 Division of Urology
- 洪啟峰 Division of Urology
- Chuan-Shu Chen Division of Urology
- Cheng-Kuang Yang Division of Urology
- 裘坤元 Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張英勛 Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
165 participants
